Previous 10 | Next 10 |
NEW YORK, NY and SAN DIEGO, CA, April 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – As previously announced, Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop...
The Company Recently Received a Sizable Purchase Order From Japan and Continues to Experience Strong Levels of Interest Through its ALIBABA Portal NEW YORK, NY - ( NewMediaWire ) - April 17, 2020 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the ȁ...
NEW YORK, NY, April 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...
NEW YORK, NY, April 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...
NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...
NEW YORK, NY, April 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...
NEW YORK, NY and SAN DIEGO, CA, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop a rapid, multiplexed COVID-19 ...
On Sunday March 29, 2020 - The Company Set New Daily Records for: Revenue Generated and Number of Individual Transactions NEW YORK, NY - ( NewMediaWire ) - March 30, 2020 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a rev...
NEW YORK, NY, March 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...
The Company’s Initial Production Run Totals 8,750 Blister Packs of Peach-Lemon Flavor – Cannabigerol (“CBG”) Infused Version of Tauri-Gum™ NEW YORK, NY, March 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (...
News, Short Squeeze, Breakout and More Instantly...
Tauriga Sciences Inc (TAUG) is expected to report for Q3 2023
NEW YORK, NY - ( NewMediaWire ) - May 13, 2022 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York-based diversified Life Sciences and Pharmaceutical Development Company, today announced that the online shopping research platform, FindT...
New York, NY, May 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences and Pharmaceutical Development Company, today announced that its Chief Ex...